Skip to main content
Top
Published in: Digestive Diseases and Sciences 11/2011

01-11-2011 | Original Article

Telephone Reminder Call in Addition to Mailing Notification Improved the Acceptance Rate of Colonoscopy in Patients with a Positive Fecal Immunochemical Test

Authors: Jae Myung Cha, Joung Il Lee, Kwang Ro Joo, Hyun Phil Shin, Jae Jun Park

Published in: Digestive Diseases and Sciences | Issue 11/2011

Login to get access

Abstract

Background and Aims

Colorectal cancer (CRC) screening with a fecal immunochemical test (FIT) reduces CRC mortality; however, the acceptance rate of a colonoscopy in patients with a positive FIT was not high. The aim of this study was therefore to determine whether a telephone reminder call could increase the acceptance rate of colonoscopy in patients with a positive FIT.

Methods

We performed FITs for asymptomatic participants aged 50 years or older. For patients with a positive FIT, a colonoscopy was recommended via mailing notification only (control group) or via a telephone reminder call after mailing notification (intervention group). The calls informed patients about the significance of a positive FIT and encouraged a colonoscopy following positive FITs.

Results

The FIT results were positive in 90 of 8,318 patients who received FITs. Fifty patients were advised to receive colonoscopy via mailing notification only, and 40 patients were advised via both a telephone reminder call and a mailing notification. The acceptance rate of colonoscopy was significantly higher in the intervention group than in the control group (p = 0.038). The lesion-detection rate for an advanced neoplasia was also significantly higher in the intervention group than in the control group (p = 0.046). According to multivariate logistic regression analysis, a telephone reminder was a significant determinant of colonoscopy acceptance in patients with a positive FIT (OR 4.33; 95% CI, 1.19–15.75; p = 0.026).

Conclusions

Telephone reminder calls in addition to mailing notification improved the acceptance rate of colonoscopy in patients with a positive FIT.
Literature
1.
2.
go back to reference Sung JJ, Lau JY, Goh KL, Leung WK. Asia Pacific Working Group on Colorectal Cancer. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol. 2005;6:871–876.PubMedCrossRef Sung JJ, Lau JY, Goh KL, Leung WK. Asia Pacific Working Group on Colorectal Cancer. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol. 2005;6:871–876.PubMedCrossRef
3.
go back to reference Choi KS, Jun JK, Lee HY, et al. Increasing uptake of colorectal cancer screening in Korea: a population-based study. BMC Public health. 2010;10:265. PMID:20492654. Choi KS, Jun JK, Lee HY, et al. Increasing uptake of colorectal cancer screening in Korea: a population-based study. BMC Public health. 2010;10:265. PMID:20492654.
4.
go back to reference Winawer SJ, Flehinger BJ, Schottenfeld D, Miller DG. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst. 1993;85:1311–1318.PubMedCrossRef Winawer SJ, Flehinger BJ, Schottenfeld D, Miller DG. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst. 1993;85:1311–1318.PubMedCrossRef
5.
go back to reference Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343:1603–1607.PubMedCrossRef Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343:1603–1607.PubMedCrossRef
6.
go back to reference Atkin WS, Cuzick J, Northover JM, Whynes DK. Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet. 1993;341:736–740.PubMedCrossRef Atkin WS, Cuzick J, Northover JM, Whynes DK. Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet. 1993;341:736–740.PubMedCrossRef
7.
go back to reference Whitlock EP, Lin JS, Liles E, Beil TL, Fu R. Screening of colorectal cancer: a targeted, updated systematic review for the US Preventive Services Task Force. Ann Intern Med. 2008;149:638–658.PubMed Whitlock EP, Lin JS, Liles E, Beil TL, Fu R. Screening of colorectal cancer: a targeted, updated systematic review for the US Preventive Services Task Force. Ann Intern Med. 2008;149:638–658.PubMed
8.
go back to reference Shim JI, Kim Y, Han MA, et al. Results of colorectal cancer screening of the national cancer screening program in Korea, 2008. Cancer Res Treat. 2010;42:191–198.PubMedCrossRef Shim JI, Kim Y, Han MA, et al. Results of colorectal cancer screening of the national cancer screening program in Korea, 2008. Cancer Res Treat. 2010;42:191–198.PubMedCrossRef
9.
10.
go back to reference Knight KK, Fielding JE, Battista RN. US Preventive Services Task Force. Occult blood screening for colorectal cancer. JAMA. 1989;261:586–593.PubMedCrossRef Knight KK, Fielding JE, Battista RN. US Preventive Services Task Force. Occult blood screening for colorectal cancer. JAMA. 1989;261:586–593.PubMedCrossRef
11.
go back to reference Lim JU, Bae NY, Song WK, Cha JM, Lee JI. The significance of fecal immunochemical test to screen for colorectal cancer in National Cancer Screening Program. Intest Res. 2010;8:126–134.CrossRef Lim JU, Bae NY, Song WK, Cha JM, Lee JI. The significance of fecal immunochemical test to screen for colorectal cancer in National Cancer Screening Program. Intest Res. 2010;8:126–134.CrossRef
12.
go back to reference UK Colorectal Cancer Screening Pilot Group. Results of the first round of a demonstration plot of screening for colorectal cancer in the United Kingdom. BMJ. 2004;329:133–135.CrossRef UK Colorectal Cancer Screening Pilot Group. Results of the first round of a demonstration plot of screening for colorectal cancer in the United Kingdom. BMJ. 2004;329:133–135.CrossRef
13.
go back to reference Basch CE, Wolf RL, Brouse CH, et al. Telephone outreach to increase colorectal cancer screening in an urban minority population. Am J Public Health. 2006;96:2246–2253.PubMedCrossRef Basch CE, Wolf RL, Brouse CH, et al. Telephone outreach to increase colorectal cancer screening in an urban minority population. Am J Public Health. 2006;96:2246–2253.PubMedCrossRef
14.
go back to reference Myers RE, Hyslop T, Sifri R, et al. Tailored navigation in colorectal cancer screening. Med Care. 2008;46:S123–S131.PubMedCrossRef Myers RE, Hyslop T, Sifri R, et al. Tailored navigation in colorectal cancer screening. Med Care. 2008;46:S123–S131.PubMedCrossRef
15.
go back to reference Myers RE, Sifri R, Hyslop T, et al. A randomized controlled trial of the impact of targeted and tailored interventions on colorectal cancer screening. Cancer. 2007;110:2083–2091.PubMedCrossRef Myers RE, Sifri R, Hyslop T, et al. A randomized controlled trial of the impact of targeted and tailored interventions on colorectal cancer screening. Cancer. 2007;110:2083–2091.PubMedCrossRef
16.
go back to reference Vernon SW. Participation in colorectal cancer screening: a review. J Natl Cancer Inst. 1997;89:1406–1422.PubMedCrossRef Vernon SW. Participation in colorectal cancer screening: a review. J Natl Cancer Inst. 1997;89:1406–1422.PubMedCrossRef
17.
go back to reference Rodger J, Steele RJ. Telephone assessment increases uptake of colonoscopy in a FOBT colorectal cancer-screening programme. J Med Screen. 2008;15:105–107.PubMedCrossRef Rodger J, Steele RJ. Telephone assessment increases uptake of colonoscopy in a FOBT colorectal cancer-screening programme. J Med Screen. 2008;15:105–107.PubMedCrossRef
18.
go back to reference Han MA, Choi KS, Jun JK, Kim Y, Park EC, Lee HY. Factors associated with the intention to have colorectal cancer screening in Korean adults. Eur J Cancer Care (Engl). 2011;20:475–482.CrossRef Han MA, Choi KS, Jun JK, Kim Y, Park EC, Lee HY. Factors associated with the intention to have colorectal cancer screening in Korean adults. Eur J Cancer Care (Engl). 2011;20:475–482.CrossRef
19.
go back to reference Slater P, Fich A, Zimerman J, Ever-Hadani P, Rachmilewitz D. Recruitment of subjects for fecal occult blood screening: a comparison of two methods in Jerusalem. J Clin Gastroenterol. 1985;7:51–54.PubMedCrossRef Slater P, Fich A, Zimerman J, Ever-Hadani P, Rachmilewitz D. Recruitment of subjects for fecal occult blood screening: a comparison of two methods in Jerusalem. J Clin Gastroenterol. 1985;7:51–54.PubMedCrossRef
20.
go back to reference Stokamer CL, Tenner CT, Chaudhuri J, Vazquez E, Bini EJ. Randomized controlled trial of the impact of intensive patient education on compliance with fecal occult blood testing. J Gen Intern Med. 2005;20:278–282.PubMedCrossRef Stokamer CL, Tenner CT, Chaudhuri J, Vazquez E, Bini EJ. Randomized controlled trial of the impact of intensive patient education on compliance with fecal occult blood testing. J Gen Intern Med. 2005;20:278–282.PubMedCrossRef
21.
go back to reference Khubchandani IT, Karamchandani MC, Kleckner FS, et al. Mass screening for colorectal cancer. Dis Colon Rectum. 1989;32:754–758.PubMedCrossRef Khubchandani IT, Karamchandani MC, Kleckner FS, et al. Mass screening for colorectal cancer. Dis Colon Rectum. 1989;32:754–758.PubMedCrossRef
22.
go back to reference Grazzini G, Gastiglione G, Isu A, et al. Colorectal cancer screening by fecal occult blood testing: results of a population-based experience. Tumori. 2000;86:384–388.PubMed Grazzini G, Gastiglione G, Isu A, et al. Colorectal cancer screening by fecal occult blood testing: results of a population-based experience. Tumori. 2000;86:384–388.PubMed
23.
go back to reference Kronborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348:1467–1471.PubMedCrossRef Kronborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348:1467–1471.PubMedCrossRef
24.
go back to reference Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472–1477.PubMedCrossRef Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472–1477.PubMedCrossRef
25.
go back to reference Leard LE, Savides TJ, Ganiats TG. Patient preferences for colorectal cancer screening. J Fam Prac. 1997;45:211–218. Leard LE, Savides TJ, Ganiats TG. Patient preferences for colorectal cancer screening. J Fam Prac. 1997;45:211–218.
26.
go back to reference Ling BS, Moskowitz MA, Wachs D, Pearson B, Schroy PC. Attitudes toward colorectal cancer screening tests. J Gen Intern Med. 2001;16:822–830.PubMedCrossRef Ling BS, Moskowitz MA, Wachs D, Pearson B, Schroy PC. Attitudes toward colorectal cancer screening tests. J Gen Intern Med. 2001;16:822–830.PubMedCrossRef
27.
go back to reference Thompson RS, Michnich ME, Gray J, Friedlander L, Gilson B. Maximizing compliance with hemoccult screening for colon cancer in clinical practice. Med Care. 1986;24:904–914.PubMedCrossRef Thompson RS, Michnich ME, Gray J, Friedlander L, Gilson B. Maximizing compliance with hemoccult screening for colon cancer in clinical practice. Med Care. 1986;24:904–914.PubMedCrossRef
Metadata
Title
Telephone Reminder Call in Addition to Mailing Notification Improved the Acceptance Rate of Colonoscopy in Patients with a Positive Fecal Immunochemical Test
Authors
Jae Myung Cha
Joung Il Lee
Kwang Ro Joo
Hyun Phil Shin
Jae Jun Park
Publication date
01-11-2011
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 11/2011
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-011-1720-0

Other articles of this Issue 11/2011

Digestive Diseases and Sciences 11/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.